UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,426.00 -12.50 (-0.51%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,842.62 +170.38 (+0.31%)
Verona Pharma plc (VRNA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.04B |
| Enterprise value | 832.61M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.61 |
| Enterprise value/revenue | 2.53k |
| Enterprise value/EBITDA | -20.89 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -40.86% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 23.07 |
| 52-week low 3 | 11.83 |
| 50-day moving average 3 | 15.55 |
| 200-day moving average 3 | 16.37 |
Share statistics
| Avg vol (3-month) 3 | 474.43k |
| Avg vol (10-day) 3 | 665.19k |
| Shares outstanding 5 | 81.08M |
| Implied shares outstanding 6 | 48.09M |
| Float 8 | 513.09M |
| % held by insiders 1 | 3.91% |
| % held by institutions 1 | 87.99% |
| Shares short (30 Apr 2024) 4 | 6.11M |
| Short ratio (30 Apr 2024) 4 | 14.58 |
| Short % of float (30 Apr 2024) 4 | 8.26% |
| Short % of shares outstanding (30 Apr 2024) 4 | 7.90% |
| Shares short (prior month 28 Mar 2024) 4 | 6.56M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -72.5M |
| Net income avi to common (ttm) | -63.42M |
| Diluted EPS (ttm) | -0.80 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | 20.59% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 3.10 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.